Experiment: 7MZW

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
2	2D 1H-15N HSQC	300 uM [U-100% 13C; U-100% 15N; U-100% 2H] Anaplastic lymphoma kinase ALK extracellular domain 673-1025, 20 mM sodium phosphate, 150 mM sodium chloride, 0.1 % sodium azide	90% H2O/10% D2O	170 mM	7.0	1 atm	308	Bruker AVANCE NEO 850
3	2D 1H-13C HSQC aromatic	400 uM U-2H,15N-1H13C_AILMTV_1H,13C-FY (Ce1,2) Anaplastic lymphoma kinase ALK extracellular domain 673-1025, 20 mM sodium phosphate, 150 mM sodium chloride, 0.1 % sodium azide	90% H2O/10% D2O	170 mM	7.0	1 atm	308	Bruker AVANCE NEO 700
4	2D 1H-13C HMQC	400 uM U-2H,15N-1H13C_AILMTV_1H,13C-FY (Ce1,2) Anaplastic lymphoma kinase ALK extracellular domain 673-1025, 20 mM sodium phosphate, 150 mM sodium chloride, 0.1 % sodium azide	90% H2O/10% D2O	170 mM	7.0	1 atm	308	Bruker AVANCE NEO 1100
5	3D CBCA(CO)NH	300 uM [U-100% 13C; U-100% 15N; U-100% 2H] Anaplastic lymphoma kinase ALK extracellular domain 673-1025, 20 mM sodium phosphate, 150 mM sodium chloride, 0.1 % sodium azide	90% H2O/10% D2O	170 mM	7.0	1 atm	308	Bruker AVANCE NEO 850
17	3D HN(CO)CA	300 uM [U-100% 13C; U-100% 15N; U-100% 2H] Anaplastic lymphoma kinase ALK extracellular domain 673-1025, 20 mM sodium phosphate, 150 mM sodium chloride, 0.1 % sodium azide	90% H2O/10% D2O	170 mM	7.0	1 atm	308	Bruker AVANCE NEO 850
16	3D HNCO	300 uM [U-100% 13C; U-100% 15N; U-100% 2H] Anaplastic lymphoma kinase ALK extracellular domain 673-1025, 20 mM sodium phosphate, 150 mM sodium chloride, 0.1 % sodium azide	90% H2O/10% D2O	170 mM	7.0	1 atm	308	Bruker AVANCE NEO 850
15	3D HNCACB	300 uM [U-100% 13C; U-100% 15N; U-100% 2H] Anaplastic lymphoma kinase ALK extracellular domain 673-1025, 20 mM sodium phosphate, 150 mM sodium chloride, 0.1 % sodium azide	90% H2O/10% D2O	170 mM	7.0	1 atm	308	Bruker AVANCE NEO 850
14	3D HCACO	300 uM [U-100% 13C; U-100% 15N; U-100% 2H] Anaplastic lymphoma kinase ALK extracellular domain 673-1025, 20 mM sodium phosphate, 150 mM sodium chloride, 0.1 % sodium azide	90% H2O/10% D2O	170 mM	7.0	1 atm	308	Bruker AVANCE NEO 850
13	3D 1H-15N NOESY	300 uM [U-100% 13C; U-100% 15N; U-100% 2H] Anaplastic lymphoma kinase ALK extracellular domain 673-1025, 20 mM sodium phosphate, 150 mM sodium chloride, 0.1 % sodium azide	90% H2O/10% D2O	170 mM	7.0	1 atm	308	Bruker AVANCE NEO 850
12	3D CmCmHm_NOESY	400 uM U-2H,15N-1H13C_AILMTV_1H,13C-FY (Ce1,2) Anaplastic lymphoma kinase ALK extracellular domain 673-1025, 20 mM sodium phosphate, 150 mM sodium chloride, 0.1 % sodium azide	90% H2O/10% D2O	170 mM	7.0	1 atm	308	Bruker AVANCE NEO 1100
11	3D HNH_NOESY	400 uM U-2H,15N-1H13C_AILMTV_1H,13C-FY (Ce1,2) Anaplastic lymphoma kinase ALK extracellular domain 673-1025, 20 mM sodium phosphate, 150 mM sodium chloride, 0.1 % sodium azide	90% H2O/10% D2O	170 mM	7.0	1 atm	308	Bruker AVANCE NEO 850
10	3D HaCaHa_NOESY	400 uM U-2H,15N-1H13C_AILMTV_1H,13C-FY (Ce1,2) Anaplastic lymphoma kinase ALK extracellular domain 673-1025, 20 mM sodium phosphate, 150 mM sodium chloride, 0.1 % sodium azide	90% H2O/10% D2O	170 mM	7.0	1 atm	308	Bruker AVANCE NEO 700
9	3D CaCmHm_NOESY	400 uM U-2H,15N-1H13C_AILMTV_1H,13C-FY (Ce1,2) Anaplastic lymphoma kinase ALK extracellular domain 673-1025, 20 mM sodium phosphate, 150 mM sodium chloride, 0.1 % sodium azide	90% H2O/10% D2O	170 mM	7.0	1 atm	308	Bruker AVANCE NEO 700
8	3D CmNH_NOESY	400 uM U-2H,15N-1H13C_AILMTV_1H,13C-FY (Ce1,2) Anaplastic lymphoma kinase ALK extracellular domain 673-1025, 20 mM sodium phosphate, 150 mM sodium chloride, 0.1 % sodium azide	90% H2O/10% D2O	170 mM	7.0	1 atm	308	Bruker AVANCE NEO 850
7	3D NCmHm_NOESY	400 uM U-2H,15N-1H13C_AILMTV_1H,13C-FY (Ce1,2) Anaplastic lymphoma kinase ALK extracellular domain 673-1025, 20 mM sodium phosphate, 150 mM sodium chloride, 0.1 % sodium azide	90% H2O/10% D2O	170 mM	7.0	1 atm	308	Bruker AVANCE NEO 850

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE NEO	1100
2	Bruker	AVANCE NEO	850
3	Bruker	AVANCE NEO	700

NMR Refinement
Method	Details	Software
molecular dynamics	restrained MD in explicit H2O bath	CNS

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	refinement	CNS		Brunger, Adams, Clore, Gros, Nilges and Read
2	structure calculation	CYANA		Guntert, Mumenthaler and Wuthrich
3	chemical shift assignment	I-PINE		Lee, Bahrami, Dashti, Eghbalnia, Tonelli, Westler and Markley
4	peak picking	PINE		Bahrami, Markley, Assadi, and Eghbalnia
9	collection	TopSpin	4.06	Bruker Biospin
8	peak picking	NMRFAM-SPARKY		lee
7	geometry optimization	TALOS-N		SHEN AND BAX
6	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
5	data analysis	PdbStat		tejero and montelione
10	data analysis	PSVS		Bhattacharya and Montelione

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.